Canaccord Genuity Maintains a 'Hold' on Perrigo (PRGO) After Meeting with CFO; Pullback May Create Opportunity
PRGO Hot Sheet
Rating Summary:8 Buy, 4 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 19 | Down: 16 | New: 82
Canaccord Genuity maintains a 'Hold' on Perrigo Co. (NASDAQ: PRGO) price target of $105.00.
Analyst, Randall Stanicky, said, "We’ve taken a fresh look at PRGO following fiscal Q2/12 and two days of meetings in Canada with Perrigo CFO Judy Brown. There has been growing debate in the stock around Consumer growth and the appropriate valuation level which collectively has stalled momentum. We see the Consumer segment volatility as a timing issue ahead of a better fiscal 2013. Valuation is still a hurdle for some but
on the recent pull-back, combined with highly visible double-digit EPS growth, we are starting to see an attractive risk/reward set-up creating a favorable bias to the stock."
For an analyst ratings summary and ratings history on Perrigo Co. click here. For more ratings news on Perrigo Co. click here.
Shares of Perrigo Co. closed at $93.31 yesterday, with a 52 week range of $70.94-$104.70.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
Analyst, Randall Stanicky, said, "We’ve taken a fresh look at PRGO following fiscal Q2/12 and two days of meetings in Canada with Perrigo CFO Judy Brown. There has been growing debate in the stock around Consumer growth and the appropriate valuation level which collectively has stalled momentum. We see the Consumer segment volatility as a timing issue ahead of a better fiscal 2013. Valuation is still a hurdle for some but
on the recent pull-back, combined with highly visible double-digit EPS growth, we are starting to see an attractive risk/reward set-up creating a favorable bias to the stock."
For an analyst ratings summary and ratings history on Perrigo Co. click here. For more ratings news on Perrigo Co. click here.
Shares of Perrigo Co. closed at $93.31 yesterday, with a 52 week range of $70.94-$104.70.
Discover Wall Street's best ratings calls with the pros - Ratings Insider Elite. Free Trial!
You May Also Be Interested In
- Perrigo Receives FDA Approval for Butoconazole Nitrate 2% Vaginal Cream
- UBS Lowers Estimates and PT on Lowe's (LOW) Messy Q1, But Bullish Case Remains
- Barclays Maintains an 'Equalweight' on Apollo Commercial Real Estate Finance (ARI); Effectively Using Capital, But Shares Trading In-line Vs. Peers
Create E-mail Alert Related Categories
Analyst CommentsRelated Entities
Genuity Capital MarketsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
